TABLE 1.
Isolate | Cefoxitin screen in Vitek 2 | MIC (mg/liter) of:
|
PFGE type | spa type | PVL | SCCmec type | Resistance phenotype(s) | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxacillin in Vitek 2 | Oxacillin in WalkAway | Oxacillin by Etest | Oxacillin by microdilution | Cefoxitin by Etest | Cefoxitin by microdilution | |||||||
877 | + | 2 | >2 | 6* | >16 | 8* | >16 | 16-3 | t044 | − | IV | CIP |
1459 | + | 2 | 2 | 4* | 16 | 6* | 16 | 27-1 | t044 | + | IV | ERY, TET, FA |
1662 | + | >2 | 2 | 1.5* | 16 | 4* | >16 | 27-0 | t040 | + | IV | TET, FA |
1883 | + | 2 | 2 | 1* | >16 | 8* | >16 | 46-1 | t105 | + | nt | CIP, GEN |
2336 | − | 2 | 2 | 1* | >16 | 8* | >16 | 13-13 | t4861 | − | nt | ERY, SXT, TET, CIP, FA, SXT |
2449 | + | 2 | 2 | 0.5 | 16 | 8 | >16 | 27-5 | t044 | + | IV | ERY, TET, FA |
2582 | + | 1 | 0.5 | 0.125* | 0.5 | 6* | 16 | 44-12 | t4860 | − | IV | CIP |
2748 | − | >2 | >2 | 1.5* | 16 | 4 | 16 | 13-4 | t008 | − | IV | ERY, CIP, FOF |
2757 | + | >2 | 2 | 0.5* | 8 | 8* | 16 | 53-0 | t355 | + | V | GEN, ERY |
*, microcolonies visible; nt, not typeable; CIP, ciprofloxacin; ERY, erythromycin; TET, tetracycline; FA, fusidic acid; GEN, gentamicin; SXT, sulfamethoxazol-trimethoprim; FOF, fosfomycin.